0001140361-21-009211.txt : 20210318 0001140361-21-009211.hdr.sgml : 20210318 20210318211846 ACCESSION NUMBER: 0001140361-21-009211 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210315 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bespalko David William CENTRAL INDEX KEY: 0001848740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35569 FILM NUMBER: 21756282 MAIL ADDRESS: STREET 1: 29 CEDAR DRIVE CITY: ALLENDALE STATE: NJ ZIP: 07401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC. CENTRAL INDEX KEY: 0001092662 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880425691 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: (631) 924-1135 MAIL ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 FORMER COMPANY: FORMER CONFORMED NAME: Chembio Diagnostics Inc. DATE OF NAME CHANGE: 20040607 FORMER COMPANY: FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC DATE OF NAME CHANGE: 19990805 4 1 form4.xml FORM 4 X0306 4 2021-03-15 0001092662 CHEMBIO DIAGNOSTICS, INC. CEMI 0001848740 Bespalko David William C/O CHEMBIO DIAGNOSTICS, INC. 555 WIRELESS BOULEVARD HAUPPAUGE NY 11788 true Restricted Stock Units 2021-03-15 4 A 0 17204 0 A Common Stock 17204 17204 D Nonqualified Stock Options 4.65 2021-03-15 4 A 0 31746 0 A 2028-03-14 Common Stock 31746 31746 D Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units are scheduled to vest in three equal installments on March 15 of each of 2022, 2023 and 2024, provided they shall vest in full immediately prior to a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer), subject to continued service through each vesting date. The nonqualified stock options are scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2022 annual meeting of stockholders of the issuer and (ii) a Change in Control, subject to continued service through each vesting date. /s/ Mark L. Johnson, Attorney-in-Fact for David William Bespalko 2021-03-18